FDA — authorised 30 June 2009
- Marketing authorisation holder: AMAG PHARMS INC
- Status: approved
🇺🇸 Feraheme in United States
FDA authorised Feraheme on 30 June 2009
Marketing authorisations
FDA — authorised 30 June 2009
- Application: NDA022180
- Marketing authorisation holder: AZURITY
- Local brand name: FERAHEME
- Indication: SOLUTION — INTRAVENOUS
- Status: approved
Feraheme in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in United States
Frequently asked questions
Is Feraheme approved in United States?
Yes. FDA authorised it on 30 June 2009; FDA authorised it on 30 June 2009.
Who is the marketing authorisation holder for Feraheme in United States?
AMAG PHARMS INC holds the US marketing authorisation.